Bioline Rx reported $858K in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Arca Biopharma USD 2.23M 1.08M Dec/2025
Bio Path USD 259K 60K Mar/2026
Bioline Rx USD 858K 257K Mar/2026
Capricor Therapeutics USD 1.92M 446.47K Dec/2025